Hino, Japan

Yuri Sakai



Average Co-Inventor Count = 10.0

ph-index = 2

Forward Citations = 27(Granted Patents)


Location History:

  • Hino, JP (2009)
  • Tokyo, JP (2018 - 2021)

Company Filing History:


Years Active: 2009-2021

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Inventor Yuri Sakai

Introduction

Yuri Sakai is a notable inventor based in Hino, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic potential. With a total of 4 patents to his name, Sakai's work focuses on innovative solutions for medical challenges.

Latest Patents

Sakai's latest patents include a Pyrido[3, 4-d]pyrimidine derivative and pharmaceutically acceptable salt thereof. The purpose of this invention is to provide a compound that exhibits excellent CDK4/6 inhibitory activity. This compound is represented by a specific formula, which highlights its potential in treating various diseases. Another patent also focuses on a Pyrido[3,4-d]pyrimidine derivative with similar objectives, emphasizing the importance of this class of compounds in pharmaceutical applications.

Career Highlights

Throughout his career, Yuri Sakai has worked with prominent companies such as Teijin Pharma Limited and Teijin Limited. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in drug development.

Collaborations

Sakai has collaborated with talented individuals in his field, including Gen Unoki and Takaharu Tsutsumi. These partnerships have fostered innovation and have been instrumental in the success of his projects.

Conclusion

Yuri Sakai's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…